Figures & data
Figure 1 Flowchart showing patient disposition.
![Figure 1 Flowchart showing patient disposition.](/cms/asset/64329cf4-8e81-4cda-a5f2-8856e26b9e93/dppa_a_131158_f0001_b.jpg)
Table 1 Patient characteristics
Table 2 EQ-5D-3L VAS scores by group
Figure 2 Distribution of patients with any problem (moderate or extreme) over time, for each of the EQ-5D dimensions.
![Figure 2 Distribution of patients with any problem (moderate or extreme) over time, for each of the EQ-5D dimensions.](/cms/asset/1e21d9c3-06ff-4477-a1a5-1099fae11c05/dppa_a_131158_f0002_c.jpg)
Figure 3 Convenience and satisfaction dimension scores.
![Figure 3 Convenience and satisfaction dimension scores.](/cms/asset/df57de34-07e7-4015-9109-40be9d23f215/dppa_a_131158_f0003_c.jpg)
Table 3 PACT-Q2 scores by group
Figure 4 MMAS-8 French translation scores: distribution of patients according to adherence.
Abbreviations: DOAC, direct oral anticoagulant; MMAS-8, Morisky Medication Adherence Scale; P-DOAC, primary DOAC; P-VKA, primary VKA; S-DOAC, switch from VKA to DOAC; VKA, vitamin K antagonists.
![Figure 4 MMAS-8 French translation scores: distribution of patients according to adherence.](/cms/asset/66127101-0a7f-46be-b6de-4b6942782dfd/dppa_a_131158_f0004_c.jpg)